NCT04373096 is a NA clinical trial of current IPAC-UHN PPE in Covid19, sponsored by University Health Network, Toronto.

Who is sponsoring NCT04373096?

NCT04373096 is sponsored by University Health Network, Toronto.

What drugs are being tested in NCT04373096?

Interventions in NCT04373096: current IPAC-UHN PPE, modified IPAC-UHN PPE.

Is NCT04373096 still recruiting?

NCT04373096 is currently status unknown. Last updated 11 January 2021.

Last reviewed 2021-01-11 · How we verify

NCT04373096

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Enhanced Hood PPE to Minimize COVID-19 Transmission to Front-line Health Care Workers

Status unknown NA Last updated 11 January 2021

What this trial tests

NA trial testing current IPAC-UHN PPE in Covid19 in 42 participants. Status unknown.

Timeline

7 December 2020

Primary endpoint
31 August 2021

31 October 2021

Quick facts

Lead sponsor	University Health Network, Toronto
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	42
Start date	7 December 2020
Primary completion	31 August 2021
Estimated completion	31 October 2021
Sites	1 location across Canada

Drugs / interventions tested

current IPAC-UHN PPE
modified IPAC-UHN PPE

Conditions studied

Covid19 — all drugs for Covid19 →

Sponsor

University Health Network, Toronto

Who can join

Adults 20 to 75, any sex, with Covid19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study proposes to compare the effectiveness of two different levels of PPE in protecting front-line health care workers from self-contamination with droplets and aerosolized particles during a simulated endotracheal intubation, an aerosol-generating medical procedure.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A hood shield reduces postdoffing contamination during simulated COVID-19 airway management: an exploratory, simulation-based randomized study.
Muñoz-Leyva F, Perlas A, Chin KJ, Soheili M, et al · · 2023 · cited 1× · PMID 37020172 · DOI 10.1007/s12630-023-02400-x

Verify or expand the search:

Other recruiting trials for Covid19

Currently open trials in the same condition.

NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting

Other University Health Network, Toronto trials

Trials by the same sponsor.

NCT06831032 — Elective Adaptive Radiation With SBRT for Improved DurabilitY of Response · NA · recruiting
NCT06634056 — Pneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients U · Phase 2 · not yet recruiting
NCT06836726 — Clinical Trial to Test Efficacy of Targeting Hypoxia Combined With ARSI After First-line ARSI Therapy for Castrate Resis · Phase 2 · not yet recruiting
NCT07515651 — Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas · Phase 2 · not yet recruiting
NCT07509450 — Fecal Microbiota Transplantation in Patients Undergoing Chimeric Antigen Receptor T-cell Therapy and Allogeneic Stem Cel · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04373096 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Health Network, Toronto
Last refreshed: 11 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04373096.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing